Innovative Drug Strategies in Chronic Disease Management: Addressing Non-Adherence and Improving Therapeutic Outcomes
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 26 September 2025 | Viewed by 75
Special Issue Editors
2. Pharmacy Directorate, Castilla y León Health Council, 47007 Valladolid, Spain
3. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (Group CB21/13/00051), Carlos III Institute of Health, 28029 Madrid, Spain
Interests: pharmacology; pharmacoepidemiology; psychotropic drugs; big data analysis; real-world data; substance abuse; pharmacometrics; observational studies; meta-analysis
Special Issues, Collections and Topics in MDPI journals
Interests: psychoneuropharmacology; psychopharmacology; pharmacoepidemiology; toxicology; substance abuse
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to this Special Issue of Pharmaceuticals, entitled “Innovative Drug Strategies in Chronic Disease Management: Addressing Non-Adherence and Improving Therapeutic Outcomes”.
The increasing prevalence of chronic diseases has become one of the most important public health problems worldwide. Chronic diseases are associated with increased medication use and complex drug regimens. High medication use leads to polymedication, which is strongly associated with non-adherence and a reduced quality of life. Meanwhile, non-adherence has negative impacts in relation to clinical outcomes, such as furthering disease progression and increasing mortality, as well as in the form of rising healthcare costs.
To address these issues and improve chronic disease outcomes, methods to measure medication adherence must be implemented in daily clinical practice. The early identification of non-adherent patients will allow strategies to be implemented, to ensure the effectiveness of prescribed medications.
This Special Issue will showcase innovative research on improving medication adherence, highlighting possible new approaches to developing personalized therapeutic strategies for chronic diseases. For this Special Issue, submissions of original research articles and reviews are welcome. The selected set of manuscripts will be published as a Special Issue of Pharmaceuticals.
We look forward to receiving your contributions.
Dr. Eduardo Gutiérrez-Abejón
Prof. Dr. F. Javier Alvarez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adherence
- persistence
- chronic diseases
- therapeutic strategies
- individualized therapy
- personalized medicine
- clinical pharmacology
- clinical trials
- observational studies
- real-world data studies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
